In the present study, we attempted to rescue the dwarfism of the rdw rats using a diet supplemented with thyroid powder (T-powder) and a thyroid graft (T-graft). The infants of the rdw rat were successfully raised to a mature stage body weight, accompanied by elevation of serum growth hormone (GH) and prolactin (PRL), by the T-powder. Furthermore, the T-graft successfully increased the body weight with fertility. The serum GH and PRL levels in the T-graft rdw rat significantly increased. The serum thyroid-stimulating hormone (TSH) levels in the T-graft rdw rat were significantly decreased but were significantly higher than those in the control rat. The GH and PRL mRNA expression in the rdw rat with the T-graft was virtually the same as that of the control, but the TSH β mRNA differed from that of the control rats. Thus, the dwarfism in the rdw rat is rescued by thyroid function compensation, such as that afforded by T-powder and T-graft.
lating hormone (TSH) levels are elevated [19, 23] , implicating dysfunction of the thyroid gland. In addition, two-dimensional gel electrophoresis studies conducted on various tissues of the rdw rat have revealed that the rdw thyroid glands have a very serious abnormality in protein content [17] . In the rdw thyroid gland, the content of endoplasmic reticulum (ER) resident chaperons is significantly increased, and electron microscopic analysis conducted on the rdw rat determined beyond question that it has an abnormal thyroid gland, as indicated by missing secretory granules, a dilated ER, and nuclear dislocation [19] . These observations suggested that the primary defect in the rdw rat would be an abnormality of the thyroid gland, and sequencing of the entire Tg complementary DNA (cDNA) from the rdw rat revealed a missense mutation (G2320R) in the acetylcholinesterase-like domain at the 2320th amino acid residue [9, 12] . Thus, the accumulated evidence indicates that the missense mutation in Tg causes hypothyroidism in the rdw rat.
If the cause of rdw dwarfism is found in the thyroid gland, it should be possible to rescue the rdw rat from dwarfism by supplementary therapy of the thyroid function. In this study, we attempted to rescue the dwarfism of the rdw rat using a diet supplemented with thyroid powder (T-powder) and a thyroid graft (T-graft).
Animals
A colony of rdw rats has been maintained at the animal facility of Kitasato University School of Medicine. The animal room is air-conditioned at 24 ± 1°C, maintained at 50-60% relative humidity, and artificially illuminated daily from 0600 h to 2000 h. The rats are fed CMF pellets (Oriental Yeast Co., Ltd., Tokyo, Japan) and given water ad libitum.
Homozygous rdw rats (rdw/rdw) were obtained by mating heterozygous rats or rdw/? females with fertilizing rdw males treated with thyroid therapy. Wistar-Imamichi rats (from the Imamichi Institute for Animal Reproduction, Tsuchiura, Ibaraki, Japan), from which the rdw strain rats were derived, were used as the control animals. For the hormone and mRNA analyses, only male rats were used so as to avoid hormone variations in the females due to the stages of the estrous cycle. All groups of rats were sacrificed in the 18-20th week by decapitation under ether anesthesia for blood and pituitary gland collections. The animal procedure protocol was approved by the Animal Care and Use Committee of Kitasato University School of Medicine.
Thyroid powder (T-powder) diet supplement
The rdw rats were given a diet containing 0.025% thyroid powder (Sigma Chemical, T-1251, St. Louis, MO, USA) from 4 weeks of age immediately after weaning, and their body weights were recorded weekly up to 15 weeks of age during the diet. The rats were sacrificed in their 18th week of age during the diet with T-powder for specimens for hormone analysis.
Thyroid graft (T-graft) treatment
We grafted thyroid glands from phenotypically normal +/? rats to rdw rats. The thyroid glands were grafted under the sternohyoid muscle, with the thyroid from a +/? rat to rdw/rdw rat, under ether anesthesia. The Tgraft was performed on rats between 5 to 8 weeks of age, and the efficacy regarding body weight was observed by recording the rats' body weight. The fertility of rdw male rats with the T-graft was examined by mating them with rdw/+ female rats. The phenotypical features of the offspring obtained by mating were observed. For the hormone and mRNA analyses, we performed the T-graft treatment on the male rdw rats in the 7th week of age. The rats were sacrificed in their 18th week of age for specimens for analysis.
Hormone determination
Blood samples were obtained by decapitation under light ether anesthesia and allowed to clot at room temperature. Then, the sera were separated by centrifugation at 3,000 rpm for 15 min. The concentrations of GH, PRL, and TSH were measured using a radioimmunoassay (RIA) following a previously reported method [7] using reagents provided by the Rat Pituitary Hormone Program, NIDDK, NIH. A doubleantibody separation system was employed for RIA. The second antibody was anti-monkey IgG goat serum for GH and anti-rabbit IgG goat serum for PRL and TSH (donated by Dr. K. Wakabayashi). The standard references used were rGH RP-2 for GH, rPRL RP-3 for PRL, and rTSH RP-2 for TSH. T 4 was measured using the RIA kit (Dainabot Co., Ltd., Tokyo, Japan, T-4 RIABEAD). The detectable limit in the T 4 assays was 1 µg/dl.
Northern hybridization
The rdw rats treated with T-graft were decapitated in their 18th week of age under light ether anesthesia, as well as age-matched rdw and Wistar-Imamichi rats. Immediately afterwards, the pituitary was excised and stored at -80°C. The total RNA was denatured, fractionated in a 1% agarose gel containing formaldehyde, transferred onto a nitrocellulose membrane, and hybridized with probes as previously described [18] .
Probes
Oligo DNA probes of 42-mer complementary to the pituitary hormone mRNA were labeled at the 5' end with T4 polynucleotide kinase and [γ-
32 P] ATP. The number of amino acid residues corresponding to each probe was as follows: GH (143-156) [2] and PRL (152-165) [5] . Rat Pit-1 cDNA (826 bp) corresponding to nucleotides 104 to 928 [10] was prepared. Rat TSHβ cDNA was made by the RT-PCR method using poly (A)+ RNA prepared from normal rat pituitaries as the template and cloned into pUC118 [21] . Human glyceraldehyde-3 phosphate dehydrogenase (G3PDH) cDNA was obtained from Clontech (Palo Alto, CA, USA). The cloned cDNA was labeled by the random-primer method using [γ-32 P] dCTP.
Statistical analysis
The results of the body weights and hormone levels are expressed as mean ± SEM. The significance of the differences was calculated from one-way ANOVA and repeated measures of ANOVA, and values of P<0.05 were considered to be significant.
Growth curve of +/? and rdw/rdw rats
The growth curves of the rdw/rdw and +/? rats raised in our colony and those of the T-powder experiment are combined in Fig. 1 . A body weight difference between the normal (+/?) and rdw/rdw rats was evident from 3 to 4 weeks after birth. The body weight of the rdw/rdw rats was 42% in males and 40% in females when compared with that of the +/? rats at the adult age of 15 weeks. Figure 1 shows the effect of the T-powder on the body weight. The body weight of the T-powder rdw rats increased after taking the diet. A significant increase in body weight was observed from 2 weeks after the start of the diet. The body weight of the T-powder rdw/rdw rats was found to be between that of the untreated rdw and the normal control rats (+/?) in both males and females. The ratio (%) of the body weight in the T-powder rdw rats relative to the untreated rdw rats was 239% in males and 228% in females at the 7th week, 276% and 260% at the 10th week, and 208% and 202% at the 14th week, respectively. Thus, the body weight of the rdw rats given T-powder became 79% in males and 96% in females at the 15th week compared with that of the normal (+/?) controls. Table 1 shows the hormone levels of the T-powder rdw rats. The serum levels of GH and PRL in the rdw rats given T-powder significantly increased and were significantly different from those of the untreated rdw rats. The serum GH and PRL levels in the T-powder rdw rats were almost the same as those of the control. The T 4 and TSH levels in the T-powder rdw rats were close to those of the control rats. Figure 2 shows the effects of the T-graft treatment between 5 to 8 weeks of age on body weight. This figure shows that the T-graft successfully increased the body weight. The growth rate for catch-up due to the T-graft was higher in the younger animals than in the older ones. The T-graft rdw male rats treated at the 5, 7, or 8 weeks of age had 78%, 67%, or 52% of the +/? body weight at the 18 weeks of age respectively, and the T-graft rdw rats treated at the 5 weeks of age had 80% of the +/? body weight at 25 weeks of age under continuous observation (data not shown). The reproductive performance of male rdw rats given the T-graft at the 7 weeks of age was examined by mating with rdw/+ females. All three of the T-graft males mated with rdw/+ females were fertile with rdw/rdw and rdw/ + offspring being produced with a theoretical phenotype ratio. The hormone levels of the rdw rats treated with the T-graft are presented in Table 1 in combination with the data for the T-powder experiment. The serum GH and PRL levels in the T-graft group was increased significantly compared with those of the untreated rdw rat, although the levels in the T-graft group were lower than those in the control group. The serum TSH in the T-graft group was at levels between those of the control and untreated rdw rats; the values of the T-graft group were significantly different from those of the other two groups. The serum T 4 levels of the T-graft group had similar characteristics to the case of TSH; T-powder denotes the rdw/rdw rats given a diet containing 0.025% T-powder and T-graft is the rdw/rdw rats grafted with the thyroid glands of +/? rdw colony rats. Values indicate means ± SEM with numbers of rats in parentheses. a, b, c, d) Significant differences are indicated by letter superscripts which differ from each other at P<0.01 (ANOVA). The T-graft was performed at 7 weeks of age. Values with different letter superscripts are significantly different (P<0.01). Filters were exposed for 9 h (GH), 114 h (PRL), 1.5 h (TSHβ), and 114 h (Pit-1) at -80°C with an intensifying screen. The T-graft was performed at 7 weeks of age, and the T-grafted rats were sacrificed at 18 weeks of age.
Body weight and hormone levels (GH, PRL, TSH, and T 4 ) in T-powder rdw rats

Body weight, reproductive performance, serum hormone levels (GH, PRL, TSH, and T 4 ), and pituitary mRNA expression in T-graft rdw rats
Fig. 2.
Growth curves of rdw/rdw male rats with T-grafts at various times. The T-graft was performed at 5, 7, or 8 weeks of age. Increase in body weight was observed until the 18 weeks of age. The number of examined rats is indicated in parentheses. The body weight increased after the T-graft.
the T 4 levels in the T-graft group were between those of the control and rdw groups with a significant difference. Figure 3 shows the expression of GH, PRL, TSHβ, and Pit-1 mRNAs in the pituitary gland of the T-graft group. The expression of GH and PRL mRNAs in the T-graft rdw rats was virtually the same as that of the controls. The expression of the Pit-1 mRNA in the Tgraft rdw rats was virtually the same as those of the control and rdw/rdw rats. Thus, we concluded that the expression of Pit-1 mRNA was not affected by the change of thyroid hormone levels due to thyroid therapy. However, the expression of TSHβ mRNA in the Tgraft rdw rats differed from that of the control rats but was essentially the same as that of the untreated rdw rats.
Our experiment using T-powder clearly demonstrates that the symptoms of rdw dwarfism depend on the rat's hypothyroidism. The thyroid therapy used on the rdw infants caused the animals to mature in body weight and fertility (data not shown), accompanied by an increase in serum GH and PRL (Table 1 ). These evidences mean that the hypothalamus and the pituitary had functioned normally in the rdw rats after the thyroid therapy. As is well known, secretion disorder of the thyroid hormone occurs as a result of dysfunction of the thyroid or a reduction in bioactivity due to an abnormality in the TSH molecule.
The T-graft study proved that endogenous TSH secreted in rdw rats stimulates the thyroid grafted from normal rats (+/?) of the rdw colony. The fact that T 4 levels increased in the rdw rats with the T-graft, accompanied with a reduction in the serum TSH, indicates the normality of the TSH bioactivity in the rdw rat. The reason for the insufficient hormone recovery following the T-graft, in contrast to the results obtained with the T-powder treatment, may be due to insufficient thyroid hormone release from the grafted thyroid. The insufficient hormone recovery in the T-graft rats might also be caused by the timing of the graft treatment. The increased expression of GH and PRL mRNAs in the T-graft rdw rats strongly supports the idea that rdw dwarfism depends on dysfunction of the thyroid gland and that thyroid dysfunction due to Tg gene abnormality produces dwarfism characterized by the rdw phenotype. Thus, we concluded that the rdw rat has primary hypothyroidism. Umezu et al. have recently shown that male rdw rats show recovery of body weight with fertility in response to T 4 supplementary therapy from 3 weeks of age until adulthood [24] .
We were able to raise rdw infants to a mature stage in body weight and fertility by grafting thyroid glands from phenotypically normal animals. Moreover, the response element of the thyroid hormone receptor (TRE) for the expression of GH is located upstream of the GH gene; therefore, the thyroid hormone directly responds to GH to control the secretion of GH [14, 20] . The reduction of GH secretion in rdw rats should be considered only as a secondary effect in their dwarfism because the lack of thyroid hormone is the primary reason for the reduction in GH. A reduction in PRL production may also take place through a secondary effect mediated by the reduced thyroid hormone. Although the thyroid hormone decreases PRL mRNA in cultured pituitary cells [15, 16] , its in vivo effect is still unclear [6] . Its effect on PRL production may be indirect; in other words, a reduction in thyroid hormone production may prevent the function of PRL-producing cells since lactotrophs appear to come from a somatotroph or presomatotroph cell at the early stage of neonatal development [4] .
Based on thyroid therapy studies, we confirmed that the cause of rdw dwarfism is found in the thyroid gland. In regard to the insufficient recovery of body weight in both the T-powder and T-graft rats, we assume that the serum T 4 concentration of the rdw rats receiving in thyroid therapies was lower than that in the control rats at the beginning of the thyroid therapies, particularly in comparison with T 4 administration by Umezu et al. [24] . Umezu et al. have also suggested that T 4 administration in the neonatal period plays a pivotal role in the normalization of testicular weight and function in hypothyroid rdw rats. We cannot definitely explain why the TSHβ mRNA content remains high in the T-graft rdw rats. We speculate that the T 4 secretion from the grafted thyroid is insufficient for the reduction in the TSHβ mRNA content in the T-graft rdw rats.
The rdw thyroid is lighter than that of its normal counterpart in absolute weight but is almost normal in relative weight to the whole body [19] . Upon gross inspection, however, the rdw thyroid is pale and transparent in comparison with a normal one, which is dark-brown. The hypothyroidism of the rdw rat is dis-tinct from that of hypothyroid animal models, such as cog/cog [3] and hyt/hyt mice [1, 22] , in both gross inspection and specific regard to thyroid weight. The cog/cog thyroid is more than ten times the normal gland in absolute weight [3] . The hyt/hyt thyroid is a very small bi-lobed gland situated in the normal position [1, 22] . The causal gene of hypothyroidism has been identified as Tg in cog/cog [11] and the TSH receptor [8] in hyt/hyt.
Based on the findings of in this study, and the results of our previous studies, such as protein analysis [17] , morphological findings [19] , and sequencing of the entire Tg cDNA from the rdw rat [9, 12] , we concluded that the synthesized abnormal Tg forms a complex with the chaperons and accumulates in the ER, resulting in dramatic swelling of the ER. As a result, the rdw rat has severe hypothyroidism and dwarfism. It was expected that it would be possible to rescue the rdw rat from its dwarfism using a supplementary therapy of thyroid function because the primary cause of rdw dwarfism present in the thyroid gland is a Tg gene mutation [9, 12] . In conclusion, rdw dwarfism is rescued or canceled by thyroid function therapy. Furthermore, the rdw rat is a useful animal model, as it has primary hypothyroidism without goiter, different from the cog/cog mouse Tg gene mutation, which results in goiter [10] .
